MUVAXX Trademark

Trademark Overview

On Wednesday, June 3, 2020, a trademark application was filed for MUVAXX with the United States Patent and Trademark Office. The USPTO has given the MUVAXX trademark a serial number of 88946818. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 15, 2024. This trademark is owned by Sorrento Therapeutics, Inc.. The MUVAXX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Transdermal drug delivery device containing pharmaceutical preparations for the treatment of viral infections

Microneedle devices for medical purposes, namely, for use in the transdermal delivery of drugs, biologics, and vaccines, sold without medication
muvaxx

General Information

Serial Number88946818
Word MarkMUVAXX
Filing DateWednesday, June 3, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Goods and ServicesTransdermal drug delivery device containing pharmaceutical preparations for the treatment of viral infections
Goods and ServicesMicroneedle devices for medical purposes, namely, for use in the transdermal delivery of drugs, biologics, and vaccines, sold without medication

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 25, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, June 25, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVIVASOR, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121
Party NameSorrento Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameSorrento Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Saturday, June 6, 2020NEW APPLICATION ENTERED
Thursday, June 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 3, 2020ASSIGNED TO EXAMINER
Friday, September 4, 2020NON-FINAL ACTION WRITTEN
Friday, September 4, 2020NON-FINAL ACTION E-MAILED
Friday, September 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 3, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 3, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 2, 2021SOU TEAS EXTENSION RECEIVED
Thursday, December 2, 2021SOU EXTENSION 1 FILED
Thursday, December 2, 2021SOU EXTENSION 1 GRANTED
Saturday, December 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 18, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 18, 2022SOU EXTENSION 2 FILED
Wednesday, May 18, 2022SOU EXTENSION 2 GRANTED
Friday, May 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 10, 2022SOU TEAS EXTENSION RECEIVED
Thursday, November 10, 2022SOU EXTENSION 3 FILED
Thursday, November 10, 2022SOU EXTENSION 3 GRANTED
Saturday, November 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 6, 2023SOU EXTENSION 4 FILED
Tuesday, June 6, 2023SOU EXTENSION 4 GRANTED
Thursday, June 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 8, 2023SOU EXTENSION 5 FILED
Monday, January 8, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, January 8, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 8, 2024TEAS PETITION TO REVIVE RECEIVED
Monday, January 8, 2024PETITION TO REVIVE-GRANTED
Monday, January 8, 2024NOTICE OF REVIVAL - E-MAILED
Monday, January 8, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, January 8, 2024NOTICE OF REVIVAL - E-MAILED
Wednesday, February 28, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 29, 2024SOU EXTENSION 5 GRANTED
Friday, March 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 24, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, July 15, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 15, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

muvaxx transdermal delivery drugs namely purposes biologics vaccines medication without sold